VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GPAT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GPATGP-Act III Acquisition Corp.
$11.07$398M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. GPAT
  4. Financial Ratios

GP-Act III Acquisition Corp. (GPAT) Financial Ratios

Latest Ratios: P/E Ratio 27.0x · EV/EBITDA N/A · ROE 4.1%. (2020–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

GPAT Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2020
Market Cap$398M$307M$186M———
Enterprise Value$398M$308M$186M———
P/E Ratio →27.0026.0721.57———
P/S Ratio——————
P/B Ratio1.081.040.66———
P/FCF——————
P/OCF——————

P/E links to full P/E history page with 30-year chart

GPAT EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2020
EV / Revenue——————
EV / EBITDA——21.39———
EV / EBIT——21.39———
EV / FCF——————

GPAT Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2020
Gross Margin——————
Operating Margin——————
Net Profit Margin——————

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2020
ROE4.1%4.1%6.1%——-18.9%
ROA3.9%3.9%5.8%-1.8%-4.6%-1.4%
ROIC-0.1%-0.1%-0.3%-2.3%-9.0%—
ROCE-0.2%-0.2%-0.4%——-18.9%

GPAT Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2020
Debt / Equity0.000.000.00——5.38
Debt / EBITDA——0.05—116147.75—
Net Debt / Equity—0.00-0.00——5.38
Net Debt / EBITDA——-0.01—115708.25—
Debt / FCF——————
Interest Coverage——————

GPAT Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2020
Current Ratio0.300.301.070.010.00—
Quick Ratio0.300.301.070.010.00—
Cash Ratio0.180.180.770.000.00—
Asset Turnover——————
Inventory Turnover——————
Days Sales Outstanding——————

GPAT Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2020
Dividend Yield——————
Payout Ratio——————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2020
Earnings Yield3.7%3.8%4.6%———
FCF Yield——————
Buyback Yield0.0%0.0%0.0%———
Total Shareholder Yield0.0%0.0%0.0%———
Shares Outstanding—$29M$18M$31M$31M$31M

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidation and deal-sourcing failure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Market Pricing Reflects Deal Uncertainty

According to current market data, GPAT trades at a P/B ratio of 1.06, which suggests that investors are pricing the equity near its net asset value, reflecting a neutral outlook on the sponsor's ability to secure a premium-generating business combination before the looming liquidation deadline.

The P/E ratio of 26.54 is largely irrelevant given the lack of operational earnings, serving more as a reflection of interest income on trust assets rather than business performance. Investors should monitor this multiple as a proxy for market sentiment regarding the sponsor's reputation rather than as a fundamental valuation of the underlying shell entity.

Operational Runway Remains Severely Constrained

Based on the most recent quarterly filings, the company's current ratio has deteriorated to 0.17, indicating that the entity lacks sufficient liquid assets to cover its administrative obligations without continued reliance on sponsor-provided working capital loans to sustain its pre-merger operational existence.

The sharp decline in the current ratio from 1.76 in 2024Q2 to 0.17 in 2026Q1 highlights a structural vulnerability that warrants close investigation. This liquidity profile suggests that the company is increasingly dependent on external capital infusions, which may create pressure to finalize a deal prematurely to avoid insolvency.

Capital Efficiency Obscured by Structure

As reported in financial statements, the ROIC has fluctuated near zero or negative levels, with the most recent 2026Q1 figure of -0.1% confirming that the vehicle is currently incapable of generating a return on invested capital prior to the execution of a business combination.

The negative ROIC trend over the last ten quarters reflects the inherent nature of a SPAC, where capital is trapped in a trust account while administrative costs erode the sponsor's equity. This metric should not be interpreted as a failure of management, but rather as a structural reality of the shell vehicle's current pre-operational phase.

Misapplication of Traditional Profitability Metrics

As highlighted in recent SEC filings, the use of standard profitability ratios like net margin is fundamentally misapplied to GPAT, as these metrics obscure the fact that the company is a non-operational shell vehicle that does not yet possess a revenue-generating business model.

Investors should instead focus on the 'burn rate' of administrative expenses and the remaining trust value per share, as these provide a more accurate assessment of the company's health. Relying on traditional margin analysis may lead to erroneous conclusions regarding the entity's ability to sustain its operations in the long term.

Download Financial Ratios Data

Includes 30+ ratios · 5 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

GPAT — Frequently Asked Questions

Quick answers to the most common questions about buying GPAT stock.

What is GP-Act III Acquisition Corp.'s P/E ratio?

GP-Act III Acquisition Corp.'s current P/E ratio is 27.0x. The historical average is 23.8x. This places it at the 100th percentile of its historical range.

What is GP-Act III Acquisition Corp.'s ROE?

GP-Act III Acquisition Corp.'s return on equity (ROE) is 4.1%. The historical average is -2.9%.

Is GPAT stock overvalued?

Based on historical data, GP-Act III Acquisition Corp. is trading at a P/E of 27.0x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.